argenx SE Logo

argenx SE (ARGX)

Euronext

Currency in EUR
728.40
+22.80 (+3.23%)

Closed

Oct 9, 2026

Day's Range

719.20
745.60

52 wk Range

568.40
925.00

Overview - ARGX - argenx SE

Key Statistics

Valuation

Enterprise Value

41.86B

P/E (Trailing)

‪36.63‬

P/E (Forward)

‪26.14‬

PEG Ratio

‪26.14‬

Price / Sales (TTM)

‪9.94‬

Price / Book

‪7.30‬

EV / EBITDA

‪29.58‬

Profitability

Gross Margin

‪90.42%‬

Profit Margin

‪32.26%‬

Operating Margin

‪31.99%‬

Return on Assets

‪11.63%‬

Return on Equity

‪23.63%‬

Ownership

Shares Outstanding

62.53M

Float

62.43M

Held by Insiders

‪0.0089%‬

Held by Institutions

‪48.56%‬

Price stats

Beta

‪-0.02‬

50-Day Avg

‪825.05‬

200-Day Avg

‪732.35‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Buy

10 analysts

Average price target

‪€ 937.66‬

News Teaser - ARGX - argenx SE

News & Analysis

View all news

Market Cap - ARGX - argenx SE

Peers - ARGX - argenx SE

Peer Comparison

Compared with companies in Biotechnology listed on Euronext.

Profile Summary - ARGX - argenx SE

About

argenx SE is a commercial-stage, global, fully-integrated biopharmaceutical company headquartered in Amsterdam, Netherlands, specializing in the development of differentiated antibody-based therapies for severe autoimmune diseases. The company leverages its Immunology Innovation Program (IIP), a discovery engine that…

SectorHealthcare
IndustryBiotechnology
Employees1.59K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.